MET
MetLife Inc
NYSE: MET · FINANCIAL SERVICES · INSURANCE - LIFE
$77.98
+1.23% today
Updated 2026-06-05
Market cap
$53.29B
P/E ratio
16.02
P/S ratio
0.69x
EPS (TTM)
$5.17
Dividend yield
2.77%
52W range
$67 – $85
Volume
3.4M
WallStSmart proprietary scores
68
out of 100
Grade: B
Buy
Investment rating
6.0
Growth
B6.8
Quality
B5.0
Profitability
C+7.7
Valuation
B+4/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$94.79
+21.56%
12-Month target
$69.66
-10.67%
Intrinsic (DCF)
—
Margin of safety
—
4 Strong Buy8 Buy6 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $2.69B — positive
Risks
- Thin margins at 4.67%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $67.97B | $67.71B | $70.98B | $77.08B | $77.58B | $80.0B |
| Net income | $5.28B | $1.58B | $4.43B | $3.38B | $1.19B | — |
| EPS | — | — | — | — | $5.17 | $9.89 |
| Free cash flow | $13.20B | $13.09B | $15.12B | $18.11B | $2.69B | — |
| Profit margin | 7.77% | 2.33% | 6.24% | 4.38% | 4.67% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-01 | DEBEL, MARLENE | Sale | 10,712 | — |
| 2026-06-01 | DEBEL, MARLENE | Sale | 10,600 | — |
| 2026-06-01 | DEBEL, MARLENE | Sale | 21,312 | $81.59 |
Peer comparison
Smart narrative
MetLife Inc trades at $77.98. representing a P/E of 16.02x trailing earnings. Our Smart Value Score of 68/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $77.58B. with profit margins at 4.67%.
Frequently asked questions
What is MetLife Inc's stock price?
MetLife Inc (MET) trades at $77.98, on a P/E of 16.0x and a P/S of 0.7x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is MetLife Inc overvalued?
MetLife Inc carries a Smart Value Score of 68/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read.
What is the price target of MetLife Inc (MET)?
The 12-month analyst consensus target is $94.79, about 21.6% above the current $77.98. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of MET by 2030?
Our research-backed model puts the 2030 base case at $1,711.42, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is MetLife Inc's revenue?
MetLife Inc's trailing twelve-month revenue is $77.58B, and our model projects it reaching about $93.80B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorFINANCIAL SERVICES
IndustryINSURANCE - LIFE
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.69x
ROE13.24%
Beta0.78
50D MA$77.14
200D MA$77.84
Shares out0.64B
Float0.54B
Short ratio—
Avg volume3.4M
Performance
1 week+0.00%
1 month+5.90%
3 months+23.09%
YTD+7.03%
1 year—
3 years—
5 years—